FIBROGEN INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2014 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Fibrogen Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2014 to Q4 2023.
  • Fibrogen Inc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $535M, a 11.9% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $535M +$57M +11.9% Dec 31, 2023 10-K 2024-02-26
Q4 2022 $478M +$68.2M +16.6% Dec 31, 2022 10-K 2024-02-26
Q4 2021 $410M +$72M +21.3% Dec 31, 2021 10-K 2023-02-27
Q4 2020 $338M +$124M +58% Dec 31, 2020 10-K/A 2022-03-04
Q4 2019 $214M +$19.9M +10.2% Dec 31, 2019 10-K 2021-03-01
Q4 2018 $194M +$34.4M +21.6% Dec 31, 2018 10-K 2020-03-02
Q4 2017 $160M +$30.5M +23.7% Dec 31, 2017 10-K 2019-02-27
Q4 2016 $129M +$12.3M +10.5% Dec 31, 2016 10-K 2018-02-27
Q4 2015 $117M +$22M +23.2% Dec 31, 2015 10-K 2017-03-01
Q4 2014 $94.7M Dec 31, 2014 10-K 2016-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.